blog

Industry insights from our own scientists, publicists, developers, designers, strategists and more.

Our experts have spent their careers learning their craft, honing their skills and implementing the most effective marketing, engagement and public relations strategies to help healthcare and science brands transform the world. Let's dive in, shall we?

Our latest posts

Changing the DNA of medicine with the world’s first CRISPR therapy

Friday was a monumental day for those living with sickle cell and those pursuing cell and gene therapy solutions for various diseases.

Katy Steele, Scientific Content Writer | December 12, 2023

FDA | FDA Approved

Regulatory Review: Unsung FDA approvals for rare disease in the 3rd quarter

In Q3 2022, several rare disease therapies became the first approved for their indications. Read more about under-the-radar FDA approvals for rare disease.

Katy Steele, Scientific Content Writer | October 18, 2022

FDA | FDA Approved | Rare Disease

A Few 2019 Wraps and 2020 Trends to Watch

We've brought together a few of our favorite year-end wrap-ups and some 2020 predictions for digital and life sciences.

HDMZ Team | January 20, 2020

FDA | Life Sciences | Patient Empowerment | Pharma | Technology

Do You Know What You're Sharing? The FDA Does.

On July 29, 2010, the FDA issued a warning letter to Novartis stating that content shared through Facebook and ShareThis functionality.

HDMZ Staff | August 12, 2010

FDA | Regulatory | Facebook | Social Media